All - 123,355 Studies Found

Recruiting : SOM230 Ectopic ACTH-producing Tumors
: Ectopic ACTH Syndrome
: 2016-04-26
: Drug: Pasireotide Other Name: SOM230
Terminated : Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
:
  • Pancreatic Neoplasm
  • Pituitary Neoplasm
  • Nelson Syndrome : 2009-07-22
    : Drug: pasireotide LAR Investigational drug pasireotide LAR was supplied in vials with 20 mg or 40 mg pow
Recruiting : Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
:
  • Cushing's Syndrome
  • Ectopic Corticotropin Syndrome
  • : 2015-06-08
    : Drug: Osilodrostat Osilodrostat will be prescribed by the investigator. Osirodrostat 1 mg, 5 mg, 10 mg,
Recruiting : Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
: Cushing Syndrome
: 2013-12-21
:
  • Drug: F-DOPA PET Scan
  • Drug: Mifepristone
Terminated : Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
: Cushing's Syndrome
: 2007-01-12
: Drug: Mifepristone Singe dose
Completed : Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
:
  • Cushing's Disease
  • Cushing's Syndrome

: 2011-06-07
: Drug: Mifepristone mifepristone at doses from 300mg/day up to 1200mg/day
Completed : An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
: Cushing's Syndrome
: 2009-07-09
: Drug: mifepristone Mifepristone 300 mg to 1200 mg once daily
Terminated : A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
: Cushing's Syndrome
: 2008-11-20
: Drug: Cushing's syndrome confirmation Other Name: Provide access to standard test procedures.
Completed : A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
: Cushing's Syndrome
: 2007-12-05
: Drug: mifepristone Patients take mifepristone by mouth once a day. The dose is increased during schedule
Recruiting : Treatment of Cushing's Disease With R-roscovitine
: Cushings Disease
: 2014-05-21
: Drug: R-roscovitine See Arm Description Other Names:
Next >>>